Little is known about the pharmacological activities of Iris adriatica (Iridaceae), a plant endemic to Dalmatia (Croatia). We therefore performed a bioassay-guided fractionation including highperformance counter current chromatography (HPCCC) and antibacterial tests using Mycobacterium smegmatis mc² 155. One obtained fraction was found to be antimycobacterially active with a MIC of 64 mg L -1
habit and yellow or violet solitary flowers. I. adriatica is listed as one of about 350 species of the genus Iris, where it is considered as one of the smallest species in this genus (1, 2) . I. adriatica has not been researched extensively and therefore limited data is available. Rhizomes of Iris species were traditionally used in European medicine as expectorant, stimulant, diuretic, emetic drugs and supplements in toothpowders. Also, a specialty for teething children, Rhizoma Iridis pro infantibus, is reported, which consists of long pieces of rhizomes that are chewed for pain relief (3) . In Traditional Chinese Medicine, the mixture "She-gan" including Iris species is used against cough and pharyngitis (4). Furthermore, a variety of activities against cancer, inflammation, hyperlipidemia and neurodegenerative diseases are reported for various Iris species (5, 6) . The postulated toxicity of Iris, causing diarrhea, nausea and skin irritations (7), is not documented in literature for I. adriatica. Iridin and myristic acid are mentioned as irritant substances that can be found at high concentrations in rhizomes of plants of this genus (7).
Thus far, over 30 compounds have been isolated and identified from the rhizomes of I. adriatica (8, 9) . A detailed metabolic profiling of phenolic compounds of the rhizomes of native populations of I. adriatica was recently published by our group (8) . Mainly phenolic compounds such as isoflavones are found in large numbers and quantities, followed by xanthones and benzophenones. Representing the most abundant substance group, germanaism B was found as the leading isoflavone. Irilone, another found isoflavone was reported to be antidiabetically active by inhibiting α-amylase and to be of phytoestrogenic nature when used in combination with red clover (10, 11) . Concerning xanthones, mangiferin and irisxanthone are heading the list (8) . In literature, mangiferin is reported to possess analgesic, antidepressant, antidiabetic, antiinflammatory, antioxidant, antiproliferative, antiviral, diuretic and immunomodulatory properties (12, 13) . Some isoflavones, namely, irigenin and irilone, were reported to be potent inhibitors of the cytochrome P450 1A enzyme and to be of chemopreventive nature (3) . At a glance, several pharmacologically promising activities were reported for compounds found in I. adriatica, but no antibacterial data was reported for this species.
Developing resistance rates challenge health care systems and research worldwide. Due to the fact that bacteria have rapidly become resistant to antibiotics on the market, it is not surprising that the World Health Organization reports increasing numbers of resistant tuberculosis (TB) being by now the leading cause of death caused by a single infectious agent. In 2017, 82 % of all resistant TB cases were of multidrug-resistant manner (14). Therefore, new strategies to combat increasing resistance rates are urgently needed. One of the approaches to limit resistance development is the application of so called efflux pump inhibitors, which are able to block the outward transport of antibiotics from cells (15) . The boundless pool of plants in the world is still an insufficiently explored field for new antibacterials and efflux pump inhibitors. A continued study of Newman et al. has shown the high impact of plants as sources for new drugs (16) . Therefore, exploitation of the so far unresearched plant material is of high importance to obtain new antibacterials for the fight against resistant microbes.
Antibacterial effect of Iris sp. was already detected against Escherichia coli, Pseudomonas aeruginosa, Salmonella typhi and Staphylococcus aureus (17) . Interestingly, in that study it was found that Proteus vulgaris seems to be resistant to extracts of five Iris species. The reported antituberculotic activity of I. germanica leaves could not be confirmed by literature research, which only resulted in negative documentation against Mycobacterium tuberculo-sis (5) . The aim of our study was to assess whether Iris adriatica is an antimycobacterial agent, which was facilitated by bioassay-guided fractionation. In addition to the already putative antiinflammatory, phytoestrogenic, antidiabetic and chemopreventive activities of compounds found in I. adriatica, we would like to shed light on the potential of this plant against mycobacteria.
EXPERIMENTAL

Plant material and extraction
Rhizomes of I. adriatica were collected at native sites in April 2016 (Table S1 ) and airdried for one month, followed by Soxhlet extraction of 261.5 g plant material with methanol (extraction yield 16.3 %). As plant material of endemic I. adriatica from its original habitats was not available in large amounts, in this study we also included a pure compound isolated from a commercial sample of Radix Iridis (which can include rhizomes originating from I. germanica, I. pallida or I. florentina (18) , Kottas Pharma (Austria) based on the fact that this substance was also identified in I. adriatica (8) .
Analysis of extracts, fractions and pure compounds by UHPLC-PDA-ESI-MS
Analysis was carried out according to a method recently published by our group (8) . In short, a Dionex Ultimate 3000 RS LC system coupled to a LTQ XL linear ion-trap mass spectrometer equipped with an ESI ion source (all components Thermo Scientific) and a Zorbax SB-C18 Rapid Resolution HD column, 100 × 2.1 mm, 1.8 µm particle size (Agilent), were used. Elution with 0.1 % formic acid in water (A) and gradient grade acetonitrile (B) started with 8 % B, increasing to 45 % B 0-9 min; 9-13 min 45 % B to 100 % B; 13-15 min 100 % B; 15-15.5 min 100 % B to 8 % B, equilibrating for 8 min at a flow rate of 0.39 mL min -1
. Column temperature was set to 35 °C, injection volume was kept at 2 µL. PDA detection was performed in the wavelength range of 190 to 500 nm. Mass spectra were recorded in negative and positive ion modes in the m/z range of 50 to 2000 amu. (source voltage 3.5 kV (ESI pos), 5.0 kV (ESI neg); capillary temperature 300 °C; source temperature 350 °C; sheath gas flow 65 arb (arbitrary units), auxiliary gas flow 15 arb).
Fractionation and isolation of compounds from I. adriatica
Fractionation was carried out with vacuum column chromatography (CC) using silica gel 60 (Normasil 60; 0.040-0.063 mm VWR Chemicals) and solvents following the gradient: n-hexane/EtAc 80:20, n-hexane/EtAc 50:50, n-hexane/EtAc 0:100, methanol/EtAc 20:80, methanol/EtAc 35:65, methanol/EtAc 50:50, methanol/EtAc 100:0 and methanol/water 90:10 (19). 20.2 g of crude methanolic extract was applied to 200 g of silica gel (resulting in 31 fractions (F1-31). Obtained fractions were combined to 10 subfractions according to their thin layer chromatographic profile (TLC plates silica gel 60 F 254 , Merck, mobile phase toluene/ethyl formate/formic acid 5:4:1). Irilone was purified from F9-10 (representing subfraction 2, eluted with n-hexane/EtAc 0:100) by subsequent high-performance countercurrent chromatography (HPCCC) fractionation. Spectrum HPCCC (Dynamic Extractions Co. Ltd., Slough, Berkshire, UK) was equipped with analytical (22 mL, 0.8 mm i.d., 1 mL sample loop) and semipreparative (137 mL, 1.6 mm i.d., 6 mL sample loop) coils. The following parameters were used: semi-preparative coil; rotation speed 1600 rpm, flow-rate 6 mL min Fractionation of F9-10 (100 mg) was also carried out by open column chromatography using Sephadex LH-20 as stationary phase (column 2 × 45 cm), while EtAc and methanol (9:1, V/V) served as eluents. Obtained fractions were merged to 6 fractions, from which sub-fractions were collected using semipreparative reversed phase (C18) high performance liquid chromatography. Semipreparative HPLC was carried out on a Shimadzu system (CBM-20A controller, LC-20AT solvent delivery module, SIL-10AF autosampler, CTO-20AC column oven, SPD-M20A diode array detector, FRC-10A fraction collector) using a Luna C18(2), 250 × 10 mm, 10 µm column (Phenomenex). One fraction, designated as F-IT, was obtained by elution with water:methanol (45:55) with a flow rate of 4 ml min -1 between 16 and 17.7 min by structure elucidation using NMR (see Table S2 ); it was found to be a mixture of iristectorigenin A (major amount) and irigenin to a smaller extent (ratio ca. 80: 20) . This fraction was also tested against mycobacteria in order to draw conclusions on structure-activity relationships.
Fractionation and isolation of compounds from Radix Iridis
In UHPLC-PDA-MS analysis, it became obvious that irigenin was present in much larger amounts in a commercial sample of Radix Iridis (see Fig. S1 ); hence, this material was used for isolation of this isoflavonoid. An ethanolic Soxhlet extract of Radix Iridis was prepared by extracting 300 g of powdered plant material with ethanol (96 %) for 4 h to yield 31.1 g extract (10.4 % extraction yield). After pre-fractionation by vacuum CC on silica (Normasil 60; 0.040-0.063 mm VWR Chemicals) with a gradient as used for I. adriatica (see above), HPCCC fractionation of fraction C (100 mg, eluted with EtAc from the silica column) with n-hexane/EtAc/2-propanol/methanol/ (5:6:2:4.5:6, V/V) yielded pure irigenin (13.1 mg) in 16-19 min. This substance was also identified in I. adriatica and therefore subjected to antimycobacterial testing in order to gain an insight into the activities exerted by pure compounds.
Structures of isolated isoflavonoids were confirmed by NMR analysis ( 1 H, 13 C, HMBC, HSQC); data are presented in Table S2 .
Antimycobacterial assays
Extracts, fractions and pure compounds were tested at an established minimum inhi bitory concentration (MIC) and modulation factor (MF) assay against the strain Mycobacterium smegmatis mc² 155 (ATCC 700084) (20) . MIC assay was carried out with the crude extract at the initial concentration of 512 mg L . Testing agents were diluted in dimethyl sulfoxide prior to testing and added into 96-well plates in duplicate, serially diluted with Mueller Hinton Broth medium and incubated with a 5 × 10 5 cfu mL -1 bacterial inoculum for 72 hours at 37 °C (n = 2). Isoniazid was added as a control substance to each plate for intra-plate monitoring and both sterile and growth control were performed on each plate. The same conditions were applied for the MF assay, whereby the testing concentration was set to ½ of the determined MIC. In our model, we standardly used ethidium bromide (EtBr) in order to reveal the resistance modifying effects based on efflux pump inhibition, since EtBr has been shown to be the substrate of many efflux pumps. The modulation factor clarifies the MIC reduction of the antibiotic in the presence of a modulator. The higher the MF, the lower is the amount of substance needed to exert the same antibacterial effect. All plates, independently of the assay, were evaluated with a colorimetric assay using MTT after 30 min of additional incubation.
RESULTS AND DISCUSSION
Analysis of the crude extracts, fractions and pure compounds obtained after isolation procedures was done by UHPLC-PDA-ESI-MS n as previously reported (8). Identification was deduced from mass spectral fragments as well as UV data, in case of isolated compounds finally confirmed by two dimensional NMR analysis. Figure 1 shows a representative ESI-MS base peak chromatogram (positive mode) and a UV chromatogram (290 nm) of the methanolic extract of I. adriatica rhizomes with the compounds relevant for our study on antimycobacterial activity.
Testing of the methanolic crude extract revealed no antimycobacterial effect against M. smegmatis. The modulation factor assay indicated a promising MF of 4 which means a 4-fold reduction of MIC value of the testing agent (in our case EtBr) when used in combination with the modulator (plant extract/pure compound). This extract was therefore further separated to possibly assign a pure compound of particular antibacterial value. Except for fraction F9-10 with a MIC of 64 mg L -1 , no antimycobacterial effect was documented for I. adriatica fractions. Also, pure compounds were not able to inhibit mycobacterial growth sufficiently when tested in the MIC assay. MF testing revealed F9-10, F11-14 and F15-18 as moderately active, resulting in a MF of 2. Regarding pure compounds, the fraction F-B (2,4,6-trihydroxy-4-methoxy-benzophenone), irigenin and irilone were found to be responsible for the resistance-modulatory activity of I. adriatica (Table I) . Hence, the resis- (22) . Fig. 2 shows the corresponding structural formulas of the essential pure compounds that were found to be active in I. adriatica, revealing diverse structural features, i.e., a highly methoxylated isoflavone (irigenin), an isoflavone bearing a methylene dioxy residue (irilone) and a methoxy lated benzophenone; hence, no clear conclusions on structure activity relationships can be drawn. Using LC-PDA-ESI-MS analysis (8), the following compounds were identified in fractions F19-20 and F21-24: germanaism B and irisxanthone (both fractions),
and germanaism E (only in F21-24). These compounds were not able to elicit any antimycobacterial or resistance-modulatory activity. These results point to the conclusion that the glycoside of iristectorigenin A (F21-24, MF of 1) is of less resistance-modulatory potency compared to aglycone (F-IT).
The results of irigenin and irilone are in line with those of biochanin A (genistein-4´-methyl ether), for which efflux-modulatory activity against M. smegmatis was previously reported (20) . Pure compounds of I. adriatica are therefore promising candidates for subsequent studies. 
CONCLUSIONS
We were able to identify two isoflavones and one benzophenone with resistance-modulatory activity in I. adriatica and thus provide the first evidence of this plant being an antimycobacterial agent against fast-growing mycobacteria such as Mycobacterium smegmatis mc² 155. A follow-up study would be of interest to identify the antibacterial agent in F9-10, which is still unknown. In case of restricted availability of plant material from endemic Iris species, related commercial sources of other Iris species can be employed for extraction and isolation of pure compounds. HPCCC seems to be an excellent tool for this purpose, providing pure target compounds in sufficient amounts to further test them for their efflux pump-inhibitory potential, which in turn could be helpful as adjuvants in the therapy against resistant bacteria.
Acronyms, abbreviations, symbols. -EtAc -ethyl acetate, EtBr -ethidium bromide, MeOH -methanol, MF -modulation factor, MIC -minimum inhibitory concentration, MTT -thiazolyl blue tetrazolium bromide, TB -tuberculosis.
